Esperion Therapeutics Inc.

(ESPR) Trade

By |

Profile

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm has Business of researching, developing and commercializing therapies for the treatment of patients with the elevated LDL-C operating segment.

Contact Information

Website: www.esperion.com
Email: aschwartz@esperion.com
Main Phone: +1 734 887-3903
Address: 3891 Ranchero Drive
Address 2: Suite 150
State: MI
City / Town: Ann Arbor
Country: US
Postal Code: 48108

Issuer Information

Exchange: NSD
CEO: Timothy M. Mayleben
Employees: 193
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm has Business of researching, developing and commercializing therapies for the treatment of patients with the elevated LDL-C operating segment.

Contact Information

Website: www.esperion.com
Email: aschwartz@esperion.com
Main Phone: +1 734 887-3903
Address: 3891 Ranchero Drive
Address 2: Suite 150
State: MI
City / Town: Ann Arbor
Country: US
Postal Code: 48108

Issuer Information

Exchange: NSD
CEO: Timothy M. Mayleben
Employees: 193
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 25.55 $ -1.2 (-4.49%)
Last Price 25.55 Change $ -1.2 Change % -4.49 Tick N/A
Bid 25.53 Bid Size 1,500.00 Ask 25.81 Ask Size 100.00
Open 26.32 High 26.84 Low 25.54 Prev Close 26.75
Last Trade Volume 1.1 mi 52 Wk Hi 76.99 52 Wk Low 23.90
Market Cap 661.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 25,876,626.00 EPS (TTM) -3.88 PE Ratio -6.90 Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 8 39
Number of Buys 5 18
Number of Sells 3 21
Net Activity 6912 -1264509
Last 10 Buys Shares
Gilbert S. Omenn 1,000
Naredra D. Lalwani 1,000
Mark E. McGovern 1,000
Mark E. McGovern 1,000
Timothy M. Mayleben 1,000
Gilbert S. Omenn 1,000
Timothy M. Mayleben 1,000
Timothy M. Mayleben 1,000
Gilbert S. Omenn 1,000
Daniel S. Janney 1,000
Last 10 Sell Shares
Roger Newton 1,000
Roger Newton 1,000
Roger Newton 1,000
Roger Newton 1,000
Nicole Vitullo 1,000
Nicole Vitullo 1,000
Dov A. Goldstein 1,000
Daniel S. Janney 1,000
Daniel S. Janney 1,000
Daniel S. Janney 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 121 121 121 121
Low Target Price Estimate 32.5 32.5 41 32.5
Mean Target Price Estimate 75.31 75.31 83.75 75.31
Standard Deviation 31.9 31.9 27.6 31.9
Date of Most Recent Estimate 05/28/18 05/28/18 05/23/18 05/28/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 5 7 7
Moderate Buy 0 0 0 0
Hold 3 3 4 4
Moderate Sell 1 1 0 0
Strong Sell 1 1 0 0
Mean Rec. 2.44 2.3 1.73 1.73